Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring high enantiomeric purity. Its structure supports the creation of compounds with central nervous system activity, including potential antipsychotic and antidepressant agents. Also employed in the preparation of agrochemicals and specialty materials where fluorinated moieties enhance stability and bioavailability. Commonly utilized in asymmetric synthesis and catalysis research due to its stereogenic center and aromatic trifluoromethyl group.